Literature DB >> 26450481

Feasibility of Metabolomics Analysis of Dialysate Effluents from Patients Undergoing Peritoneal Equilibration Testing.

Dagmar Csaicsich1, Anton M Lichtenauer2, Andreas Vychytil3, David C Kasper1, Rebecca Herzog2, Christoph Aufricht1, Klaus Kratochwill4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26450481      PMCID： PMC4597995          DOI： 10.3747/pdi.2014.00118

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  8 in total

Review 1.  New insights into uremia-induced alterations in metabolic pathways.

Authors:  Eugene P Rhee; Ravi Thadhani
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-11       Impact factor: 2.894

2.  The application of multiplexed, multi-dimensional ultra-high-performance liquid chromatography/tandem mass spectrometry to the high-throughput screening of lysosomal storage disorders in newborn dried bloodspots.

Authors:  David C Kasper; Joseph Herman; Victor R De Jesus; Thomas P Mechtler; Thomas F Metz; Bori Shushan
Journal:  Rapid Commun Mass Spectrom       Date:  2010-04-15       Impact factor: 2.419

3.  Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis.

Authors:  Warwick B Dunn; Angela Summers; Marie Brown; Royston Goodacre; Mark Lambie; Tim Johnson; Martin Wilkie; Simon Davies; Nick Topley; Paul Brenchley
Journal:  Nephrol Dial Transplant       Date:  2012-01-31       Impact factor: 5.992

4.  Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids.

Authors:  Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Anton Michael Lichtenauer; Elisabeth Salzer; Michael Lechner; Lilian Kuster; Konstantin Bergmeister; Andreas Rizzi; Bernd Mayer; Christoph Aufricht
Journal:  Nephrol Dial Transplant       Date:  2011-08-19       Impact factor: 5.992

5.  Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.

Authors:  Krystyna Pawlak; Michal Mysliwiec; Dariusz Pawlak
Journal:  Thromb Res       Date:  2009-09-03       Impact factor: 3.944

6.  Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Authors:  Jörg C Schefold; Jan-Philip Zeden; Christina Fotopoulou; Stephan von Haehling; Rene Pschowski; Dietrich Hasper; Hans-Dieter Volk; Christine Schuett; Petra Reinke
Journal:  Nephrol Dial Transplant       Date:  2009-01-20       Impact factor: 5.992

Review 7.  The role of metabolites and metabolomics in clinically applicable biomarkers of disease.

Authors:  Mamas Mamas; Warwick B Dunn; Ludwig Neyses; Royston Goodacre
Journal:  Arch Toxicol       Date:  2010-10-16       Impact factor: 5.153

Review 8.  Metabolic footprinting and systems biology: the medium is the message.

Authors:  Douglas B Kell; Marie Brown; Hazel M Davey; Warwick B Dunn; Irena Spasic; Stephen G Oliver
Journal:  Nat Rev Microbiol       Date:  2005-07       Impact factor: 60.633
  8 in total
  3 in total

1.  Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.

Authors:  Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Katharina Gruber; Anton Michael Lichtenauer; Lilian Kuster; Dagmar Csaicsich; Andreas Gleiss; Seth L Alper; Christoph Aufricht; Andreas Vychytil
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

2.  Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine.

Authors:  Florian M Wiesenhofer; Rebecca Herzog; Michael Boehm; Anja Wagner; Markus Unterwurzacher; David C Kasper; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Front Physiol       Date:  2019-01-21       Impact factor: 4.566

Review 3.  Impact of Metabolomics Technologies on the Assessment of Peritoneal Membrane Profiles in Peritoneal Dialysis Patients: A Systematic Review.

Authors:  Antonia Kondou; Olga Begou; John Dotis; Vasiliki Karava; Eleftherios Panteris; Anna Taparkou; Helen Gika; Nikoleta Printza
Journal:  Metabolites       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.